. Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol 288: H13-H21, 2005. First published September 2, 2004; doi:10.1152/ ajpheart.00629.2004.-Because systems controlled by basal NAD(P)H oxidase activity appear to contribute to differences in responses of endothelium-removed bovine coronary (BCA) and pulmonary (BPA) arteries to hypoxia, we characterized the Nox oxidases activities present in these vascular segments and how cytosolic NAD(P)H redox systems could be controlling oxidase activity. BPA generated ϳ60 -80% more lucigenin (5 M) chemiluminescence detectable superoxide than BCA. Apocynin (10 M), a NAD(P)H oxidase inhibitor, and 6-aminonicotinamide (1 mM), a pentose phosphate inhibitor (PPP), both attenuated (approximately by 50 -70%) superoxide detected in BPA and BCA. There was no significant difference in the expression of Nox2 or Nox4 mRNA or protein detected by Western blot analysis. NADPH and NADH increased superoxide in homogenates and isolated microsomal membrane fractions in a manner consistent with BPA and BCA having similar levels of oxidase activity. BPA had 4.2-fold higher levels of NADPH than BCA. The activity and protein levels of glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting PPP enzyme generating cytosolic NADPH, were 1.5-fold higher in BPA than BCA. Thus BPA differ from BCA in that they have higher levels of G6PD activity, NADPH, and superoxide. Because both arteries have similar levels of Nox expression and activity, elevated levels of cytosolic NADPH may contribute to increased superoxide in BPA.
OUR PREVIOUS STUDIES characterized NAD(P)H oxidases in bovine pulmonary arteries (BPA) and bovine coronary arteries (BCA) in the context of examining their potential role in responses associated with changes in PO 2 , relaxation to both lactate and inhibiting the pentose phosphate pathway, in controlling the attenuation of relaxation to nitric oxide (NO) donors after inactivating Cu,Zn-SOD, and in stretch-induced oxidase activation (6, 9, 16 -20, 22, 23) . Many of these studies provided evidence based on the actions of lactate that increasing cytosolic NADH through the lactate dehydrogenase reaction was associated with increased superoxide (O 2 Ϫ ) or H 2 O 2 -mediated signaling responses. Whereas our initial experiments using large concentrations of lucigenin to detect O 2 Ϫ suggested a more dominant dependence of oxidase activity on NADH compared with NADPH, elevated levels of lucigenin have subsequently been reported to shift the apparent pyridine nucleotide dependence of Nox oxidases from NADPH to NADH (15, 25) . While examining how pentose phosphate pathway (PPP) inhibitors cause relaxation by lowering cytosolic NADPH, we realized that inhibition of the PPP also lowered basal levels of O 2 Ϫ or H 2 O 2 release in BCA (6) . In addition there is now strong evidence that most of the Nox-type oxidases utilize NADPH as a substrate for O 2 Ϫ production (5, 15, 25) . Thus the Nox-type oxidases in BPA and BCA could potentially use both NADH and NADPH as substrates for superoxide production as a function of the availability of these intracellular metabolites.
The levels of Nox oxidase expression, activities of these NAD(P)H oxidases, and the substrates available for Nox oxidases can be hypothesized to have a very important role in controlling the expression of oxidase activity and signaling processes regulated by the species generated. However, little is known about the influence of substrate availability for Nox oxidases in cell types, which show NADH and NADPH oxidase activities. From the initial observations that BPA showed greater basal levels of O 2 Ϫ detected with 5 M lucigenin, we investigated whether differences existed in the activity and expression of Nox oxidases present in these arteries or in factors such as substrate availability as a process regulating oxidase activity.
MATERIALS
Many of the reagents used in the present study were obtained from sources previously described (6, 9, 16 -20, 22, 23) . Most vasoactive and mechanistic probes were purchased from Sigma Chemical (St. Louis, MO).
Measurement of NAD(P)H, NAD(P)
ϩ , and ATP in BCA and BPA. Isolated endothelium-removed left anterior descending coronary and secondary branch of pulmonary arterial rings were prepared from slaughterhouse-derived bovine hearts and lungs and used in the study (6, 9, 16 -20, 22, 23) . The rings were incubated in individually thermostated (37°C) 10-ml baths (Metro Scientific) for 2 h in Krebs bicarbonate buffer (pH 7.4) containing the following (in mM): 118 NaCl, 4.7 KCl, 1.5 CaCl 2, 25 NaHCO3, 1.1 MgSO4, 1.2 KH2PO4, and 5.6 glucose, gassed with 21% O 2-5% CO2 (balance N2). After a 2-h equilibration period, the levels of NAD(P)H in BCA were determined by HPLC using adaptations of previously published methods (6, 7) . Briefly, BCA and BPA were pretreated with and without different drugs and immediately frozen in liquid nitrogen. The frozen tissues were crushed and homogenized in an extraction medium consisting of 0.02 N NaOH, containing 0.5 mM cysteine at 0°C. The extracts were then heated at 60°C for 10 min and neutralized with 2 ml of 0.25 M glycylglycine buffer, pH 7.6. Acidic extracts were prepared by homogenizing the tissues in hot 0.1 N HCl followed by neutralization. The NAD(P)H was eluted on a reverse-phase HPLC column (4.6 ϫ 250 mm; Bondapak C 18, Shiseido) at room temperature using HP 1100 Series (Agilent Technologies) and buffer system consisting of 100 mM potassium phosphate (pH 6.0) (buffer A), and 100 mM potassium phosphate (pH 6.0) containing 5% methanol (buffer B). The column was eluted with 100% buffer A from 0 to 8.5 min, 80% buffer A plus 20% buffer B from 8.5 to 14.5 min, and 100% buffer B from 14.5 to 40 min. The flow rate was 1.0 ml/min, and the ultraviolet absorbance was monitored at 260 nm.
Determination of glucose-6-phosphate dehydrogenase activity and glucose-6-phosphate levels in BCA and BPA. Glucose-6-phosphate dehydrogenase (G6PD) activity was measured as previously described (27) . Briefly, enzyme activity was determined in BPA and BCA homogenates using a plate-reader spectrophotometer (Bio-Tek PowerWave 200) by measuring the rate of increase of absorbance at 340 nm from the conversion of NADP ϩ to NADPH by G6PD. Substrate concentrations used were glucose-6-phosphate (G6P, 200 M) and NADP ϩ (100 M). G6P levels were determined using the method described by Jungling et al. (11) . This method was adopted after a slight modification. G6P level was determined in homogenate (50 l) incubated in 400 l K2HPO4 buffer (pH 7.6) containing NADP ϩ (27 mM), flavin mononucleotide (20 M), G6PD (350 U/ml), and dithiothreitol (12.5 mM). After incubation for 30 min at 37°C, increase in fluorescence from the conversion of NADP ϩ to NADPH was estimated using fluorescence method described above.
Measurement of superoxide levels in BCA and BPA. With the use of previously described methods (6, 19, 20) , BCA and BPA rings were pretreated with or without drugs in the tissue bath and were placed in plastic scintillation minivials containing 5 M lucigenin for the detection of O 2 Ϫ and other additions in a final volume of 1 ml of air-equilibrated Krebs solution buffered with 10 mM HEPES-NaOH (pH 7.4).
To detect O 2 Ϫ in BCA and BPA homogenates and isolated microsomal membrane fractions, we employed our previously published methods (19) . In brief, BPA or BCA were homogenized in the Eblerbach homogenizer after the tissue was digested in MOPS (50 mM)-surcose (250 mM) buffer (pH 7.4) containing collagenase (1 mg/ml), elastase (0.125 mg/ml), and trypsin inhibitor (0.25 mg/ml). The homogenate was filtered through cheesecloth, and 10 l were used to estimate O 2 Ϫ levels. To prepare microsomal membrane-enriched fractions, the homogenate was centrifuged at 25,000 g, and the postmitochondrial fraction was further centrifuged at 100,000 g. The pellet was redissolved in MOPS-sucrose buffer, and 10 l of the microsomal membrane fraction were used in the assay measure O 2 Ϫ . Lucigenin chemiluminescence was measured in a liquid scintillation counter (LS6000IC, Beckman Instruments) at ϳ37°C, and data are reported as counts per minute per gram of BCA or BPA and counts per minute per milligram of protein after background subtraction.
RNA isolation and QRT-PCR to detect Nox2 and Nox4 in BCA and BPA. Total RNA was prepared as described previously (4) . QRT-PCR was performed to quantify mRNA levels. With the use of total RNA, a reverse transcription reaction was carried out using oligo-dT and SuperScript III (Invitrogen; Calsbad, CA). The first-strand cDNAs were amplified and message levels quantified by real-time detection using a Stratagene MX3000p (Strategene, La Jolla, CA). The housekeeping gene ␤-actin was used for normalization. Sequences of oligonucleotides from 5Ј to 3Ј for Nox2 and Nox4 were GCAGGAG AAGAACAACACGGCTGCTTATTAAGGGTGTCAGCC and AT-CACTGAACTATGAGGTTAGCCTGGTCTGTTCTCTTGCCAAA-ACT, respectively.
Western blot analysis to determine Nox2 and Nox4 in BCA and BPA. BCA and BPA homogenates for Western blot analysis was prepared using previously published methods (22) . Briefly, frozen arterial segments were pulverized under liquid nitrogen and placed in a homogenization buffer [60 mM Tris, 10 mM EGTA, 2 mM EDTA, protease inhibitor cocktails (Sigma), pH 7.5]. The tubes were centrifuged at 14,000 rpm, the supernatant was isolated, and protein levels were assayed by the Bradford method (2) for each sample. Fifty micrograms of each sample were loaded and run on 12% SDS-PAGE gels, transferred to supported nitrocellulose membranes, and subsequently exposed to primary and secondary antibodies in 5% milk ϩ Tris-buffered saline-Tween buffers and detected by ECL on autoradiography film. Densitometry analysis was used to quantitate protein levels, and protein content was expressed as spot density. Nox1, Nox2, and Nox4, and G6PD antibodies were from Santa Cruz (Santa Cruz, CA) and Sigma-RBI, respectively, and secondary anti-rabbit and anti-mouse antibodies were from Sigma-RBI.
Statistical analysis. Chemiluminescence, pyridine nucleotide, mRNA, and Western blot data were analyzed by Student's t-tests. A Bonferroni correction was used when multiple comparisons were made. The acceptable level of significance was P Ͻ 0.05. The number of experimental determinations (n) in all cases is equal to the animals from which an arterial ring was employed for a treatment or a control group in all studies. Values are means Ϯ SE.
RESULTS

Superoxide levels detected by lucigenin chemiluminescence in BCA and BPA. Detection of O 2
Ϫ levels using lucigenin (5 M) chemiluminescence revealed that BPA rings generated ϳ60 -80% higher basal O 2 Ϫ level compared with BCA ( Fig. 1 ), This was further confirmed by a treatment of BPA with O 2 Ϫ scavengers polyethylene glycol (PEG)-SOD (137 U/ml) and tiron (10 mM), which inhibited O 2 Ϫ by 60% and 82%, respectively. Treatment of BCA with similar concentrations of PEG-SOD and tiron suppressed O 2 Ϫ levels by 80% and 93%, respectively. Because of the markedly greater amount of vascular smooth muscle cells compared with other cells present in the adventitia of the endothelium-removed conduit-sized arteries studied, the levels of O 2 Ϫ detected by lucigenin are interpreted as representing primarily the contribution of this cell type.
Determination of the influence of Nox oxidase activation and pentose phosphate pathway NADPH on O 2
Ϫ in BCA and BPA. To determine whether Nox activation by binding its p47 phox subunit was influencing the source of O 2 Ϫ that may contribute to the higher levels observed in BPA, we tested the effect of apocynin (10 M), an NAD(P)H oxidase inhibitor, on the O 2 Ϫ levels from BPA and BCA. Our data in Fig. 2 indicated that apocynin suppressed the O 2 Ϫ levels by 51% and 37% in BPA and BCA, respectively. In contrast, stimulation of NAD(P)H oxidase activity by activating protein kinase C with phorbol-12,13-dibutyrate to promote p47 phox phosphorylation and binding to Nox2 (12) significantly increased O 2 Ϫ levels in both BCA and BPA. The increase in lucigenin chemiluminescence was more than 15-fold in BPA and 5-fold in BCA, and this resulted in BPA showing 5-fold greater levels of O 2 Ϫ than BCA.
Furthermore, to investigate whether PPP-derived NADPH influences NAD(P)H oxidase activity in BCA and BPA, the effect of 6-aminonicotinamide (6-AN) (1 mM), a probe previously used by us to inhibit this pathway (6), was studied for its influence on O 2 Ϫ levels in these arterial segments (Fig. 2) . A dose of 1 mM 6-AN was selected for use based on observations that it lowered NADPH by 50 -70% in BCA and rat lungs (6, 8 Ϫ generation by these pyridine nucleotides was evaluated in BPA and BCA homogenates (see Fig. 3 ). In the BPA homogenate, NADPH (0.1-1,000 M) and NADH (0.1-1,000
Ϫ generation in a concentration-dependent Ϫ levels. Lucigenin-detectable O 2 Ϫ in both BPA (A) and BCA (B) were suppressed by 6-aminonicotinamide (6-AN; n ϭ 10 -15) and apocynin (Apo; n ϭ 5-10). However, O 2 Ϫ was markedly elevated in the BPA and BCA by phorbol-12,13-dibutyrate (PDBu; n ϭ 6 -10) stimulation of NAD(P)H oxidase activity. manner. However, at higher concentrations NADH (100 and 1,000 M) promoted significantly more O 2 Ϫ generation than NADPH. Nevertheless, at more physiologically relevant lower concentrations (e.g., 1-10 M), NADPH generated significantly higher O 2 Ϫ (see Fig. 3 , inset) than NADH. Although in BCA both NADPH and NADH elevated O 2 Ϫ levels in a concentration-dependent manner, there was no difference in the generation of O 2 Ϫ at each concentration of NADH and NADPH examined (Fig. 3) . In the microsomal membrane fraction of BPA, although a distinct NADPH-dependent production of O 2 Ϫ was observed at the 100 M concentration examined, 100 M NADH resulted in a markedly greater level of O 2 Ϫ generation. A similar pattern of NADH and NADPHdependent O 2 Ϫ production was observed in the microsomal membrane fraction obtained from BCA.
Identification mRNA for Nox2 and Nox4 by QRT-PCR in BCA and BPA. It has been reported that three of the isoforms of NAD(P)H oxidases, namely Nox1, Nox2, and Nox4, are expressed in the cultured vascular smooth muscle cells and/or intact arteries (5, 10, 26) , but a comparison of the expression of these oxidases between a pulmonary and systemic artery has not been previously reported. Hence, QRT-PCR for Nox1, Nox2, and Nox-4 was performed to determine the source of O 2 Ϫ in BPA and BCA. Although the message for Nox1 could not be detected by using several different primers designed from human and animal sequences, mRNA for both Nox2 and Nox4 were observed to be present in BPA and BCA in levels that appeared to be similar to each other (see Fig. 4 ).
Identification and expression of Nox2 and Nox4 protein by Western blot analysis.
The levels of expression of Nox2 and Nox4 in BPA were compared with the levels observed in BCA by Western blot analysis (see Fig. 4 ). SDS gel electrophoresis was performed with BPA and BCA samples to detect Nox1, Nox2, and Nox4. Our results suggest that several bands were detected with the Nox2 antibody used, with one of the bands at ϳ65 kDa, which was similar to that reported in rat and mouse models (1, 13, 14) . In addition, we have detected additional bands at ϳ120 and 50 kDa, which remain to be identified. Western blot analysis for Nox4 protein showed two bands around 80 and 65 kDa, and this is consistent with previous reports detecting bands of similar molecular mass (3, 10). An additional band at ϳ70 kDa that remains to be identified was also detected in BCA. After each blot was analyzed for Nox protein expression, each blot was stripped and reprobed for the detection of ␣-actin protein levels to confirm uniform loading (not shown). The densitometry analysis demonstrated in Fig. 4 indicates that BPA and BCA had similar levels of both Nox2 and Nox4 based on an analysis of the protein bands we could identify (65 and 80 kDa) as originating from these Nox oxidases. Nox1 could not be detected under similar conditions. 
Measurement of NADP(H), NAD(H)
, and ATP levels in BCA and BPA. Pyridine nucleotide levels in BPA and BCA were determined by HPLC. As shown in Fig. 5 , we found fourfold more NADPH levels in BPA compared with BCA. A similar difference was found in NADP ϩ levels. The NADP ϩ -to-NADPH ratio in BPA was 1.3 and in BCA was 0.6. Although we could not distinguish between cytosolic or mitochondrial NAD(H), total NADH levels estimated in BCA homogenate were higher than BPA. In contrast, NAD ϩ levels were approximately fourfold higher in BPA. Additionally, the NAD ϩ -to-NADH ratio in BPA was 16.0 and in BCA was 1.8. ATP levels were about twofold higher in BCA, even though there were no differences in O 2 consumption levels between BCA and BPA (Fig. 5, E and F) . Determination of G6PD activity and expression and G6P levels in BCA and BPA. To investigate the underlying cause for higher NADPH levels in BPA, we estimated the activity of G6PD, which is a rate-limiting enzyme in PPP, and G6P levels in coronary and pulmonary artery. Estimation of G6P levels indicated that BPA has 59% lower G6P content (Fig. 6 ). Our results indicated that BPA has 1.6-fold higher G6PD activity than estimated in BCA (Fig. 6) . Furthermore, the PPP inhibitor 6-AN (1 mM) attenuated G6PD activity in homogenates of BPA and BCA by 55% and 52%, respectively. Western blot analyses were also consistent with G6PD levels being elevated in BPA probably as a result of a higher expression of G6PD protein (Fig. 7) .
DISCUSSION
O 2
Ϫ generation in both BPA and BCA appear to originate from Nox-type NAD(P)H oxidases based on data from previous studies (16 -20, 22) in these arteries and the results of the present study. Whereas our earlier studies detected a much greater level of NADH than NADPH-dependent O 2 Ϫ generation employing larger lucigenin concentrations, when examined at lower levels of lucigenin that are thought to be free of redox cycling artifacts, NADPH oxidase activity was nearly as prominent as NADH oxidase activity in artery homogenates, especially at concentrations of NAD(P)H that are thought to be physiologically relevant. Cytosolic NAD(H) is thought to be highly oxidized as a result of the lactate dehydrogenase reaction and function of mitochondrial shuttles for NADH removal (24) . Thus it is likely that basal levels of cytosolic NADH are likely to be in the concentration range of 1 M (28), and most of the NADH that was measured probably originates from mitochondrial sources. The function of the PPP appears to control the redox status of NADP(H) in the bovine arteries examined (6), and cytosolic NADPH levels are likely to be in the range of 10 -20 M based on the measurements made in the present study. This estimate of cytosolic NADPH concentrations is based on comparisons with the tissue levels of other well-characterized metabolites such as ATP and glutathione and based on the assumption that mitochondria are only a relatively minor contributor to the levels that were measured. Thus based on the NADH and NADPH concentration dependence of O 2 Ϫ generation in BPA and BCA homogenates observed in the present study and estimates of the cytosolic levels of these metabolites that are likely to be present in these arteries, cytosolic NADPH may be a more important source of O 2 Ϫ generation than NADH under the basal conditions examined in the present study. The effects of PPP inhibition with 6-AN on the levels of detected O 2 Ϫ support these interpretations because lowering cytosolic NADPH levels by inhibiting the PPP decreased O 2 Ϫ detection. Our previous studies suggest that attempting to further lower cytosolic NADH through the lactate dehydrogenase reaction with pyruvate did not alter basal O 2 Ϫ ; however, lactate raised the levels of O 2 Ϫ detected in the arteries studied (9, 17, 18, 23) , suggesting that basal O 2 Ϫ generation is regulated by increases in cytosolic NADH levels.
The Nox oxidases present in BPA and BCA appear to be Nox2 and Nox4. Nox1 could not be detected in BCA and BPA. Nox2 is the phagocytic cell gp91
phox -type oxidase. Whereas the gp91 phox system in phagocytes has an apparent 91-kDa molecular mass due to glycosylation, the antibody used in the present study, which is selective for unique amino acid sequences on this subunit, detected proteins with molecular masses in the range of 50 -65 and 120 kDa. It is likely that the protein subunits observed with the Nox2 antibody originate Fig. 6 . Comparisons of the levels glucose-6-phosphate (G6P) and glucose-6-phosphate dehydrogenase (G6PH) in BPA and BCA. Estimation of G6P in the BPA (n ϭ 10) and BCA (n ϭ 15) indicate significant lower G6P levels in BPA (top left). Whereas G6PD activity was higher in BPA (n ϭ 20) compared with BCA (n ϭ 25), moreover G6PD activity was significantly reduced by 6-AN (bottom; n ϭ 10 -15).
from differences in glycosylation and perhaps regulation through other forms of covalent bond modification in BPA and BCA. However, nonspecific binding artifacts with BPA and BCA proteins cannot be ruled out as a source of novel bands such as the protein observed at 120 kDa because of the limited amount of studies that have been conducted with the antibody employed in the present study. In other studies, antibodies for Nox2 have detected 65-, 75-, and 110-kDa proteins (1, 13, 14) . The Nox4 antibody detected proteins with molecular masses in the region of 65 and 80 kDa, which are in the range of previously reported Nox4 subunits (3, 10) . The source of the additional band at 50 kDa, and the new band at ϳ70 kDa observed only in BCA are not known at this time. Further investigation is needed to determine whether the additional molecular mass bands observed are artifacts of the properties of the antibody used or if they originate from novel properties of the Nox oxidase subunits expressed in BPA and BCA. Based on the QRT-PCR, Western blot analyses, and the properties of O 2 Ϫ generation by oxidase activities present at physiological levels of NAD(P)H, there appear to be similar levels of Nox oxidase activity in BPA and BCA. Whereas little is known about the individual contributions of Nox2 and Nox4 containing oxidase systems to the basal levels of O 2 Ϫ that were detected, it is likely that the actions of apocynin originate from a selective inhibition of Nox2, because Nox4 does not appear to be regulated by binding of its p47 phox subunit (12) . The function of the PPP in controlling cytosolic NADPH levels may be an important factor controlling the observed elevation of basal O 2 Ϫ levels BPA compared with BCA. Although BCA contained higher levels of NADH than BPA, it is likely that this reflects a property of basal mitochondrial function such as the maintenance of higher ATP levels in BCA and not a mechanism directly controlling O 2 Ϫ levels, because most of the NADH detected is likely to be present in mitochondria. In addition, basal oxygen consumption rates were similar in BCA and BPA, and this suggests that the differences in NADH and ATP levels observed in these arteries are metabolic adaptations that are not likely to originate from factors that control mitochondrial respiration or basal levels of energy consumption. Because BPA were observed to have higher levels of G6PD expression and activity, it is likely that the known function of this enzyme as the rate-limiting step of the PPP is a primary factor in the observed higher levels of NADPH in these arteries compared with BCA. Based on the potential importance of cytosolic NADPH levels controlling basal O 2 Ϫ production, the increased activity of the PPP in BPA may be a primary factor in the generating the increased levels of O 2 Ϫ observed in these arteries compared with BCA. Observations made in this study suggest that the levels of both cytosolic NADH and NADPH are important factors influencing the Nox oxidase activity present in BPA and BCA. In previous studies, we have shown that modulating cytosolic NADH levels through the lactate dehydrogenase reaction influences responses to hypoxia-reoxygenation (23) and NO (9) potentially mediated through cGMP by alterations in the levels of hydrogen peroxide and superoxide, respectively, suggesting that basal levels of cytosolic NADH have an important role in controlling the signaling mechanisms linked to these responses. In contrast, lowering basal levels of NADPH by inhibiting the PPP decreased the levels of superoxide in both BCA and BPA, and this appears to be associated with the activation of a coordination of processes that lower intracellular calcium in a manner that appears to be independent of Nox oxidase-derived oxidant species (6) . Cytosolic NADPH-dependent systems seem designed to work in a manner that coordinate the control of both Nox activity generating reactive oxygen species (ROS) and the impact of ROS on thiol redox signaling through the influence of NADPH availability on the activities of Nox oxidases and NADPH-dependent thiol-reducing systems, including glutathione reductase and thioredoxin reductase. The higher levels of G6PD and NADPH in pulmonary arteries should also increase their resistance to other sources of oxidative stress compared with coronary arteries. Fundamental differences exist between the response of BPA and BCA to hypoxia, with BPA contracting to hypoxia through processes that appear to originate from a lowering of basal peroxide levels (21), and BCA relaxing through a mechanism associated with lowering basal levels of NADPH (7, 8) . The observed differences in control of cytosolic NADPH by the PPP between BCA and BPA may be a key factor in generating the differences in responses to hypoxia that are observed with BPA maintaining a higher basal level of Nox-derived peroxide as a result of the higher levels of NADPH present in these arteries and with hypoxia lowering NADPH in BCA as a result of the less effective ability of the PPP to compete with glycolysis potentially originating from the lower levels of G6P that are present in these vessels during hypoxia. Because mice lacking Nox2 (gp91 phox ) show a normal response to hypoxia in a model also thought to involve a hypoxia-mediated decrease in peroxide (1), the Nox4 observed to be present in BPA may be the oxygen sensor involved in the pulmonary response to hypoxia. Fig. 7 . Comparisons of the expression of G6PD in BPA and BCA. A differential expression of G6PD protein was seen in the pulmonary and coronary arteries (top). Cumulative data of G6PD Western blot analysis in BPA (n ϭ 9) and BCA (n ϭ 9) demonstrate a significantly higher G6PD protein in BPA.
